ORIGINAL ARTICLE
Are there EWSR1 rearranged cutaneous hidradenomas and mucoepidermoid carcinomas of salivary glands? A FISH study and review of the literature
 
More details
Hide details
1
Department of Pathology, Gulhane Education and Research Hospital, Etlik, Ankara, Turkey
 
2
Department of Pathology, Abdurrahman Yurtaslan Oncology Education and Research Hospital, Ankara, Turkey
 
 
Submission date: 2020-02-09
 
 
Final revision date: 2020-05-12
 
 
Acceptance date: 2020-06-29
 
 
Publication date: 2020-07-21
 
 
Pol J Pathol 2020;71(2):99-106
 
KEYWORDS
TOPICS
ABSTRACT
MAML2 rearrangements have been previously described for hidradenomas and muco-epidermoid carcinomas (MEC). However, one report showed EWSR1 rearrangement in both tumours. In this study, EWSR1 and MAML2 translocation were investigated in hidradenomas and MECs.
Specimens from thirteen MECs of the salivary glands and twenty hidradenomas of the skin were evaluated. Fluorescence in situ hybridisation (FISH) studies with EWSR1 and MAML2 break-apart probes were used.
Forty percent of hidradenomas and 84.6% of MECs showed a positive MAML2 break signal. EWSR1 break signal was absent in hidradenomas. Only two MECs showed positive EWSR1 signal and were, thus, reclassified as clear cell carcinoma (CCC). A statistically significant relationship was also observed between clear cells containing hidradenomas and the FISH status.
Despite the previous study, EWSR1 translocations could not be established in hidradenomas and MECs. The study further suggests that evaluation of EWSR1 might be obligatory for the correct diagnosis of MAML2-negative MECs to exclude the chance of CCCs. The present study also supports the notion that MAML2 can be used as a marker for hidradenomas and MECs.
REFERENCES (24)
1.
Nandeesh BN, Rajalakshmi T. A study of histopathologic spectrum of nodular hidradenoma. Am J Dermatopathol 2012; 34: 461-470.
 
2.
Kuma Y, Yamada Y, Yamamoto H, et al. A novel fusion gene CRTC3-MAML2 in hidradenoma: histopathological significance. Hum Pathol 2017; 70: 55-61.
 
3.
Möller E, Stenman G, Mandahl N, et al. POU5F1, encoding a key regulator of stem cell pluripotency, is fused to EWSR1 in hidradenoma of the skin and mucoepidermoid carcinoma of the salivary glands. J Pathol 2008; 215: 78-86.
 
4.
Antonescu CR, Zhang L, Chang NE, et al. EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty-six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene. Genes Chromosomes Cancer 2010; 49: 1114-1124.
 
5.
Hsieh MS, Wang H, Lee YH, et al. Reevaluation of MAML2 fusion-negative mucoepidermoid carcinoma: a subgroup being actually hyalinizing clear cell carcinoma of the salivary gland with EWSR1 translocation. Hum Pathol 2017; 61: 9-18.
 
6.
Zhao YN, Wang X, Liang FH, et al. Hyalinizing clear cell carcinoma of salivary glands: A retrospective study focused on uncommon morphology, immunohistochemistry, and detection of gene fusion using fluorescence in situ hybridization. Pathol Res Pract 2018; 214: 380-384.
 
7.
Elder DE, et al. WHO Classification of Skin Tumours. 4th ed. 2018. IARC Press, Lyon 2018.
 
8.
Qannam A, Bello IO. Comparison of histological grading methods in mucoepidermoid carcinoma of minor salivary glands. Indian J Pathol Microbiol 2016; 59: 457-462.
 
9.
Russell-Goldman E, Dubuc A, Hanna J. Differential Expression of PLAG1 in Apocrine and Eccrine Cutaneous Mixed Tumors: Evidence for Distinct Molecular Pathogenesis. Am J Dermatopathol 2020; 42: 251-257.
 
10.
Andersson MK, Kölby L, Nilsson JA, Stenman G. Clinical, genetic and experimental studies of the Brooke-Spiegler (CYLD) skin tumor syndrome. J Plast Surg Hand Surg 2019; 53: 71-75.
 
11.
Amin SM, Beattie A, Ling X, et al. Primary Cutaneous Mammary Analog Secretory Carcinoma With ETV6-NTRK3 Translocation. Am J Dermatopathol 2016; 38: 842-845.
 
12.
Winnes M, Mölne L, Suurküla M, et al. Frequent fusion of the CRTC1 and MAML2 genes in clear cell variants of cutaneous hidradenomas. Genes Chromosomes Cancer 2007; 46: 559-563.
 
13.
Skálová A, Stenman G, Simpson RHW, et al. The Role of Molecular Testing in the Differential Diagnosis of Salivary Gland Carcinomas. Am J Surg Pathol 2018; 42: e11-e27.
 
14.
Noujaim J, Jones RL, Swansbury J, et al. The spectrum of EWSR1-rearranged neoplasms at a tertiary sarcoma centre; assessing 772 tumour specimens and the value of current ancillary molecular diagnostic modalities. Br J Cancer 2017; 116: 669-678.
 
15.
Skálová A, Weinreb I, Hyrcza M, et al. Clear cell myoepithelial carcinoma of salivary glands showing EWSR1 rearrangement: molecular analysis of 94 salivary gland carcinomas with prominent clear cell component. Am J Surg Pathol 2015; 39: 338-348.
 
16.
Tanguay J, Weinreb I. What the EWSR1-ATF1 fusion has taught us about hyalinizing clear cell carcinoma. Head Neck Pathol 2013; 7: 28-34.
 
17.
Shah AA, LeGallo RD, van Zante A, et al. EWSR1 genetic rearrangements in salivary gland tumors: a specific and very common feature of hyalinizing clear cell carcinoma. Am J Surg Pathol 2013; 37: 571-578.
 
18.
Flucke U, Palmedo G, Blankenhorn N, et al. EWSR1 gene rearrangement occurs in a subset of cutaneous myoepithelial tumors: a study of 18 cases. Mod Pathol 2011; 24: 1444-1450.
 
19.
Kyrpychova L, Kacerovska D, Vanecek T, et al. Cutaneous hidradenoma: a study of 21 neoplasms revealing neither correlation between the cellular composition and CRTC1-MAML2 fusions nor presence of CRTC3-MAML2 fusions. Ann Diagn Pathol 2016; 23: 8-13.
 
20.
Saade RE, Bell D, Garcia J, et al. Role of CRTC1/MAML2 Translocation in the Prognosis and Clinical Outcomes of Mucoepidermoid Carcinoma. JAMA Otolaryngol Head Neck Surg 2016; 142: 234-240.
 
21.
Gorunova L, Mertens F, Mandahl N, et al. Cytogenetic heterogeneity in a clear cell hidradenoma of the skin. Cancer Genet Cytogenet 1994; 77: 26-32.
 
22.
Behboudi A, Winnes M, Gorunova L, et al. Clear cell hidradenoma of the skin – a third tumor type with a t(11;19) – associated TORC1-MAML2 gene fusion. Genes Chromosomes Cancer 2005; 43: 202-205.
 
23.
Kazakov DV, Ivan D, Kutzner H, et al. Cutaneous hidradenocarcinoma: a clinicopathological, immunohistochemical, and molecular biologic study of 14 cases, including Her2/neu gene expression/amplification, TP53 gene mutation analysis, and t(11;19) translocation. Am J Dermatopathol 2009; 31: 236-247.
 
24.
Requena L, Sangüeza O. Apocrine Hidradenoma, in Cutaneous Adnexal Neoplasms. Requena L, Sangüeza O (ed.). Springer International Publishing, Cham 2017; 81-103.
 
eISSN:2084-9869
ISSN:1233-9687
Journals System - logo
Scroll to top